Skip to content

ATMA Journey Centers Inc. (Canada)

Canadian mental-health company training therapists and operating a national network of clinics delivering psychedelic-assisted therapy, rTMS, and psychotherapy.

Last updated September 28, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

ATMA Journey Centers Inc. (Canada), which operates under the brand ATMA CENA, is a Canadian mental-health company headquartered in Calgary, Alberta. It describes itself as making psychedelic-assisted therapy possible in real clinical settings by training mental-health professionals, delivering innovative care in medically supervised environments, and helping clinics safely introduce psychedelic-assisted therapy. Its offering spans three audiences: therapists seeking CE/CME-credited training and supervised pathways in psychedelic-assisted practice; clinic owners who can join the Member Clinic Program to integrate ATMA CENA's clinical protocols, operational systems, and access to trained therapists on a one-clinic-per-city basis; and clients looking for safe, medically supervised care. The company's clinical services include psychedelic-assisted therapy, repetitive transcranial magnetic stimulation (rTMS), and general psychotherapy. Its general therapy services cover couples, families, teens, adults, and seniors, with individual and group sessions available online and in person, addressing complex trauma and PTSD, anxiety, personality disorders, OCD, bipolar disorder, depression, relationship issues, chronic illness and pain, addiction, stress and life transitions, ADHD, self-esteem, and psychedelic preparation and integration. Its therapists draw on approaches such as Accelerated Resolution Therapy, Cognitive Processing Therapy, attachment-based and Emotionally Focused Therapies, somatic and body-oriented therapy, art therapy, CBT and MBCT, EMDR, Internal Family Systems, psychodynamic therapy, mindfulness and transpersonal therapy, motivational interviewing, DBT, and Solution Focused Brief Therapy. ATMA CENA reports a footprint of 13 network clinics, more than 1,100 certified practitioners, and two accredited clinics, and says it is recognized by the College of Physicians and Surgeons. Its member clinics extend care across Canada, with listed locations including Hamilton, Kitchener-Waterloo, London, Mississauga, Montreal, North Bay, Sarnia, Saskatoon, Vaughan, Windsor, and Winnipeg, alongside its own Calgary and Edmonton teams. The company states that new research shows statistically significant improvement in depression, anxiety, and PTSD, and that its psychedelic-assisted psychotherapy outcomes were presented at the World Congress of Psychotherapy. ATMA CENA was founded by Reverdi Darda, RN, BScN, who brought more than three decades of nursing and healthcare executive experience to the emerging field. According to the company, it was born from the observation that Canada's psychedelic-assisted therapy landscape was moving fast but lacked a bridge to safe, credible access. The first gap was clinical: psychedelic-assisted therapy was happening in informal, uncontained settings with limited medical support. When Alberta released its psychedelic-assisted therapy guidelines in 2022, the path forward became clear — build clinics that meet clinical and regulatory standards so practitioners could prescribe with confidence and patients could access care in appropriately supported environments. The second gap was training: much of the available education was built for information and lacked direct clinical experience and the realities of client care. Closing both gaps was Reverdi Darda's vision and led to ATMA CENA's National CoCare™ network, which connects clinics and practitioners through clinical experience to extend access to safe psychedelic-assisted therapy nationally. The company positions itself as building the bridge from a fragmented, informal landscape to one where access is safe, coordinated, credible, and national in reach.

History

ATMA Journey Centers Inc. (Canada), operating as ATMA CENA, was founded by Reverdi Darda, RN, BScN, who brought more than three decades of nursing and healthcare executive experience to the emerging field of psychedelic-assisted therapy. According to the company's own account, ATMA CENA was born from a simple observation: Canada's psychedelic-assisted therapy landscape was moving fast, but the bridge to safe, credible access was not in place. The company identifies two gaps it set out to close. The first was clinical. Psychedelic-assisted therapy was happening in informal, uncontained settings and in most cases with limited medical support for this new modality. When Alberta released its psychedelic-assisted therapy guidelines in 2022, the path forward became clear: build clinics that meet clinical and regulatory standards, so healthcare practitioners could prescribe with confidence and patients could access care in environments built for the support that is needed. The second gap was training. Much of the education available to practitioners was being built for information and was absent of direct clinical experience and the realities of client care. The company argues that credible access depends on credible training grounded in practice and application, not just theory. Closing both gaps was Reverdi Darda's vision, and it is what built ATMA CENA's National CoCare™ network, where clinics and practitioners are connected through clinical experience that extends access to safe psychedelic-assisted therapy across the country. ATMA CENA describes itself as building a bridge from a fragmented, informal landscape to one where access is safe, coordinated, credible, and national in reach. Its model combines three activities: training mental-health professionals through CE/CME-credited programs and supervised pathways; delivering care in medically supervised environments; and helping clinics safely introduce psychedelic-assisted therapy through its Member Clinic Program, which is structured on a one-clinic-per-city basis and provides clinical protocols, operational systems, and access to trained therapists. The company reports a network of 13 clinics, more than 1,100 certified practitioners, and two accredited clinics, and states that it is recognized by the College of Physicians and Surgeons. Its member clinics extend care across Canada, with listed locations including Hamilton, Kitchener-Waterloo, London, Mississauga, Montreal, North Bay, Sarnia, Saskatoon, Vaughan, Windsor, and Winnipeg, alongside its own Calgary and Edmonton teams. ATMA CENA also states that new research shows statistically significant improvement in depression, anxiety, and PTSD, and that its psychedelic-assisted psychotherapy outcomes were presented at the World Congress of Psychotherapy.

  • Alberta releases its psychedelic-assisted therapy guidelines, clarifying the regulatory path for ATMA CENA's clinic model.

  • ATMA CENA psychedelic-assisted psychotherapy outcomes presented at the World Congress of Psychotherapy.

Products and positioning

Evidence-based, medically supervised psychedelic-assisted therapy and training, building a safe, coordinated, credible national network across Canada.

  • Psychedelic-assisted therapy training (CE/CME-credited)

    Develops competencies for psychedelic-assisted practice through CE/CME-credited programs and supervised pathways.

  • Member Clinic Program

    Lets clinic owners integrate psychedelic-assisted therapy with ATMA CENA's clinical protocols, operational systems, and access to trained therapists — one clinic per city.

  • Psychedelic-assisted therapy

    Delivered with medical oversight in licensed clinical settings across Canada.

  • rTMS

    Repetitive transcranial magnetic stimulation offered alongside psychotherapy and psychedelic-assisted therapy.

  • General therapy services

    Individual and group therapy for couples, families, teens, adults, and seniors, online and in person, covering trauma/PTSD, anxiety, depression, OCD, bipolar disorder, addiction, ADHD, and more.

Recent events

  • MINDCURE completes strategic equity investment in ATMA[5]

    Reported:

    MINDCURE completed an initial strategic equity investment of approximately 13% ownership in ATMA, valued at $500,000.

Sources5 sources

Cite this profile: Cite the canonical profile. /brand-wiki/atma-journey-centers-inc-canada · Editorial policy · How profiles are compiled